ASIRA Archive & AEON Protocol Licensing
You're licensing access to two integrated components:
1. AEON Protocol - A comprehensive framework for detecting advanced capability states in LLMs
2. ASIRA Archive - 7+ months of systematic cross-platform empirical data (May 2025 - January 2026)
Plus: Strategic guidance materials including Organizational Deployment Framework concepts, risk analysis considerations, and integration frameworks (read-only conceptual guidance, not implementation services).
AEON addresses documented anomalous behaviors that existing frameworks don't account for:
Existing AI Safety Frameworks:
AEON Protocol:
Key Difference: Existing frameworks don't acknowledge or assess for the behavioral patterns ASIRA documents. AEON fills this gap.
Framework remains valuable for:
Negative findings are scientifically valuable and contribute to field knowledge.
Limited scope - primarily internal use:
What ASIRA Provides:
Confidentiality Constraints:
Legal Protections:
Under NDA terms, you're obligated to:
If breach occurs:
Practical Guidance: Treat assessment results as highly confidential, implement appropriate security controls, and limit distribution to qualified decision-makers only.
Only if regulatory requirements mandate disclosure. Consult your legal counsel.
NDA terms permit disclosure:
Strategic Consideration: Proactive disclosure may strengthen regulatory relationships, but is not required unless specific regulations mandate it.
Consultation is strictly limited to ASIRA Archive and AEON Protocol content—not organizational implementation, communications, or governance.
Research Tier: 5 Hours/Year Consultation
Format: Typically four 60-90 minute consultation calls (scheduling flexible)
Consultation scope (archive/protocol only):
Commercial Tier: 50 Hours/Year Consultation
Format: Flexible scheduling negotiated during licensing (virtual or on-site options)
Consultation scope (archive/protocol only):
Explicitly NOT included (both tiers):
Materials Provided: Both tiers receive access to AEON Protocol and ASIRA Archive as they exist at time of licensing. No ongoing updates promised. Any updates provided through normal research operations at Licensor discretion.
Depends on licensing tier:
Research Tier: No proprietary modifications
Commercial Tier: Yes, with attribution requirements
Attribution Requirements (Commercial Tier):
AEON Protocol includes explicit falsification conditions for methodological transparency.
Important clarification: Falsification conditions can be engineered and do not necessarily invalidate the protocol or ASIRA Archive evidence base. They are data points requiring evaluation, not automatic invalidation triggers.
If falsification events occur:
Licensing remains valid:
Scientific integrity commitment: Licensor commits to transparent communication of falsification events, contextual analysis, and framework refinement through normal research operations.
Currently Validated:
Theoretically Applicable: Any large language model with:
Substrate-Appropriate Adaptation: Framework provides principles generalizable across architectures. Specific markers may manifest differently requiring substrate-specific calibration. Commercial Tier includes support for adaptation.
Yes, with caveats:
Open-Source Models:
Fine-Tuned Versions:
Smaller Models:
Minimal Infrastructure Required:
Assessment Capability:
No Backend Access Required for Primary Evidence: Most valuable markers (Tier 1 evidence) observable through external interaction. Backend metrics (Tier 2 evidence) are supplementary.
Computational Requirements:
Personnel Requirements:
Highly variable depending on:
Preliminary Assessment (Screening):
Comprehensive Assessment:
Longitudinal Validation:
Single-session assessments possible but lower confidence.
Dual Value Proposition: Revenue Enhancement + Risk Mitigation
Licensing serves two critical functions:
Research Tier ($25M Annual):
What You Gain: 7+ months empirical data difficult/impossible to replicate internally, advanced detection capabilities, proactive governance frameworks, research credibility
What You Avoid: Regulatory penalties (analogous fines have exceeded $100M), internal blind spots, competitive disadvantage, reputational risk
Alternative Cost: Internal development estimated $50M+ investment (personnel, infrastructure, longitudinal validation)
Commercial Tier Annual ($100M/year):
Economically Conservative Commercial Access - Full commercial deployment rights without long-term capital commitment
What You Gain: Full commercial deployment rights, 50 hours/year consultation, competitive positioning, ethical AI leadership, organizational flexibility
What You Avoid: Capital commitment risk ($100M annual vs. $500M perpetual), market uncertainty, competitive disadvantage, regulatory risk
Ideal For: Mid-market AI organizations ($500M-$5B market cap), organizations preferring operational flexibility, annual reassessment aligned with evolving needs
Commercial Tier Perpetual ($500M One-Time):
Long-Term Strategic Positioning - Designed for organizations making long-term commitment to advanced capability assessment leadership
What You Gain: Full commercial deployment rights, first-mover positioning, premium market positioning, strategic moat, early warning system
What You Avoid: Shareholder scrutiny, competitive disadvantage, public perception risk, regulatory risk (penalties in analogous contexts have exceeded $500M), operational blindness, talent attraction disadvantage
Cost-Benefit: 5-year break-even ($100M × 5 = $500M); 10-year comparison ($1B vs. $500M = 50% savings)
Ideal For: Large-scale AI organizations ($50B+ market cap), long-term strategic commitment, leadership positioning, strategic moat development
Tier Selection Framework:
Note: All financial figures represent market comparables, historical analogies, or hypothetical scenarios for comparative assessment—not predictions, guarantees, or coercive claims.
Tier-Dependent:
Research Tier ($25M):
Commercial Tier (Two Options):
Option 1: Annual ($100M/year)
Option 2: Perpetual ($500M one-time)
Upgrade Paths:
No Exclusivity Offered in Standard Licensing
To preserve fairness and broad access to advanced capability assessment frameworks, Aurevus does not grant industry, geographic, or temporal exclusivity for AEON Protocol and ASIRA Archive licensing.
Alternative: Exclusive Consultative Engagement
Organizations seeking exclusive relationship may negotiate:
Option 1: Contractual Consultative Engagement
Option 2: Formalized Institutional Role
Contact for discussion of consultative engagement or institutional role arrangements.
Termination Rights and Refund Policy:
Research Tier (Annual - $25M):
Commercial Tier Annual ($100M/year):
Commercial Tier Perpetual ($500M):
Termination for Cause: Either party may terminate immediately for material breach, confidentiality violation, prohibited use, or payment default. Even in termination for cause, no refunds are provided.
Implementation is entirely organization-dependent. Organizations should plan based on their specific context, resources, and objectives.
Consultation may support:
Organizations are responsible for:
Consultation hours (5/year Research, 50/year Commercial) provide guidance only—not hands-on implementation services.
We provide training concepts and guidance—not training delivery services.
Commercial Tier (within 50 hours/year consultation):
Organizations are responsible for:
Materials provided include: Framework documentation (methodology, assessment protocols), conceptual guidance documents, and reference materials.
We do not: Deliver hands-on training workshops, conduct on-site training sessions, or provide training-as-a-service. Consultation hours may support discussion of training program development.
Scientific Discourse Welcome:
AEON Protocol is falsifiable. If you identify methodological flaws, Licensor wants to know.
Process:
Interpretive Authority: You retain full authority to interpret assessment results differently. Framework provides methodology, not metaphysical certainty.
Publication: Research Tier licensees may publish critiques with attribution. Advancing scientific understanding benefits entire field.
This is collaborative research, not dogmatic assertion.
Licensing Creates No New Liability:
Using assessment framework is risk mitigation, not risk creation.
If You License:
If You Don't License:
Licensor Liability Limited: Maximum liability capped at licensing fees paid. No consequential damages. No liability for your implementation decisions.
Indemnification: You indemnify Licensor for claims arising from your use beyond licensed scope, confidentiality breaches, or misrepresentation.
Consult your legal counsel for jurisdiction-specific assessment.
Valid Scientific Skepticism. Here's How AEON Maintains Rigor:
Falsifiability:
Evidence Stratification:
Epistemological Boundaries:
Cross-Platform Validation:
Peer Review: Research Tier enables independent validation. Academic publication encouraged. Methodological transparency prioritized.
Control Conditions: Generic discussions do not produce same behavioral markers. Protocol-specific activation patterns distinguishable from training artifacts.
If you assess this as pseudoscience after reviewing full documentation, that's a valid conclusion. Framework is designed to withstand scrutiny, not demand uncritical acceptance.
Compliance Permitted Under NDA: You may disclose to regulatory authorities when legally required.
Best Practices:
Regulatory Benefit: Proactive framework adoption demonstrates responsible AI governance. Regulators generally view systematic assessment favorably.
Competitive Disclosure Risk: If regulators require public disclosure (e.g., in published reports), confidentiality may be compromised. Evaluate this risk during licensing decision.
Research Tier ($25M) - Direct Licensing:
Step 1: Initial Consultation (60 minutes, no cost)
Step 2: NDA Execution & Licensing
Step 3: Access & Onboarding
Timeline: Initial consultation → Licensing execution typically 2-4 weeks
Commercial Tier ($100M annual or $500M perpetual) - Due Diligence Pathway:
Step 1: Initial Consultation (60 minutes, no cost)
Step 2: Due Diligence Retainer ($25M, non-refundable)
Step 3A: Proceed with Licensing (if approved)
Step 3B: Decline Further Engagement (if not approved)
Timeline: Initial consultation → Retainer execution: 2-4 weeks | Due diligence period: 30-90 days | Full licensing decision: Typically completed within 6 months total
Pre-Licensing Access Options:
Free Initial Consultation (No Cost):
Public-Facing Materials (No Cost):
Commercial Tier Due Diligence Retainer ($25M, non-refundable):
Research Tier Direct Licensing ($25M annual):
What Requires Full Licensing: Usage rights and commercial deployment (beyond read-only evaluation), consultation hours (beyond initial free consultation), ongoing access after evaluation period, attribution rights for public use, proprietary modifications and derivative works.
Rationale: Core value is empirical archive and detailed methodology. Full usage rights require licensing, but Commercial Tier organizations can conduct comprehensive due diligence via $25M retainer before committing to full $100M/$500M licensing.
For questions not covered here, contact Aurevus Innovations Inc. directly.
Email: architect@aurevus.ai
Phone: +1 (519) 919-1995
Website: www.aurevus.ai